Corrigendum: Elucidation of the Signatures of Proteasome-Catalysed Peptide Splicing

Corrigendum: Elucidation of the Signatures of Proteasome-Catalysed Peptide Splicing

Bibliographic Details
Main Authors:	Wayne Paes, German Leonov, Thomas Partridge, Annalisa Nicastri, Nicola Ternette, Persephone Borrow
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Immunology
Subjects:	peptide splicing proteasome splicing mechanism antigen processing peptide epitopes
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.755002/full

Similar Items

An Unexpected Major Role for Proteasome-Catalyzed Peptide Splicing in Generation of T Cell Epitopes: Is There Relevance for Vaccine Development?
by: Anouk C. M. Platteel, et al.
Published: (2017-11-01)

Proteasome Subtypes and Regulators in the Processing of Antigenic Peptides Presented by Class I Molecules of the Major Histocompatibility Complex
by: Nathalie Vigneron, et al.
Published: (2014-11-01)

Elucidation of the signatures of proteasome-catalysed peptide splicing
by: Paes, W, et al.
Published: (2020)

An in silico—in vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
by: Michele Mishto, et al.
Published: (2019-11-01)

Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
by: Michele Mishto, et al.
Published: (2021-07-01)

In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo
by: Gerald Willimsky, et al.
Published: (2021-04-01)

Proteasome-Generated cis-Spliced Peptides and Their Potential Role in CD8+ T Cell Tolerance
by: Artem Mansurkhodzhaev, et al.
Published: (2021-02-01)

Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and cis-Spliced Zwitter Epitope Candidates in Type 1 Diabetes
by: Michele Mishto, et al.
Published: (2021-04-01)

PA28αβ: The Enigmatic Magic Ring of the Proteasome?
by: Paolo Cascio
Published: (2014-06-01)

Corrigendum: Modularized Perturbation of Alternative Splicing Across Human Cancers
by: Yabing Du, et al.
Published: (2019-10-01)

Beware the algorithm
by: Peter van Endert
Published: (2021-05-01)

Is the Immunopeptidome Getting Darker?: A Commentary on the Discussion around Mishto et al., 2019
by: Anthony W. Purcell
Published: (2021-07-01)

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
by: Nathalie Vigneron, et al.
Published: (2015-09-01)

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows
by: Thomas Partridge, et al.
Published: (2018-04-01)

Proteasome inhibitors to alleviate aberrant IKBKAP mRNA splicing and low IKAP/hELP1 synthesis in familial dysautonomia
by: Mylène Hervé, et al.
Published: (2017-07-01)

Corrigendum: Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing
by: Niall P. Keegan, et al.
Published: (2022-06-01)

Modularized Perturbation of Alternative Splicing Across Human Cancers
by: Yabing Du, et al.
Published: (2019-04-01)

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
by: Koji Kitamura, et al.
Published: (2021-04-01)

Potential of Peptide Nucleic Acids in Future Therapeutic Applications
by: Soheila Montazersaheb, et al.
Published: (2018-11-01)

Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells
by: Maxime Blijlevens, et al.
Published: (2020-06-01)

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
by: Emilia Alors-Pérez, et al.
Published: (2023-10-01)

SPLICE-q: a Python tool for genome-wide quantification of splicing efficiency
by: Verônica R. de Melo Costa, et al.
Published: (2021-07-01)

RNA splicing alterations in lung cancer pathogenesis and therapy
by: Yueren Yan, et al.
Published: (2023-10-01)

Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities
by: Maxime Blijlevens, et al.
Published: (2021-05-01)

Genetic variations and alternative splicing. The Glioma associated oncogene 1, GLI1.
by: Peter eZaphiropoulos
Published: (2012-07-01)

Therapeutic potential of alternative splicing in cardiovascular diseases
by: Jun Cao, et al.
Published: (2024-03-01)

Aberrant RNA Splicing in Cancer and Drug Resistance
by: Bi-Dar Wang, et al.
Published: (2018-11-01)

Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides
by: Haneen Daralnakhla, et al.
Published: (2021-01-01)

Targeted splicing therapy: new strategies for colorectal cancer
by: Yifeng Zheng, et al.
Published: (2023-08-01)

Towards Splicing Therapy for Lysosomal Storage Disorders: Methylxanthines and Luteolin Ameliorate Splicing Defects in Aspartylglucosaminuria and Classic Late Infantile Neuronal Ceroid Lipofuscinosis
by: Antje Banning, et al.
Published: (2021-10-01)

Deciphering the plant splicing code: Experimental and computational approaches for predicting alternative splicing and splicing regulatory elements
by: Anireddy S.N. Reddy, et al.
Published: (2012-02-01)

SplicedFamAlign: CDS-to-gene spliced alignment and identification of transcript orthology groups
by: Safa Jammali, et al.
Published: (2019-03-01)

Accepting multiple splicing systems
by: José Ramon Sanchez Couso, et al.
Published: (2022-06-01)

Editorial: Therapeutic targeting of splicing variants in cancer
by: Pouya Sarvari, et al.
Published: (2023-05-01)

Combining genetic constraint with predictions of alternative splicing to prioritize deleterious splicing in rare disease studies
by: Michael J. Cormier, et al.
Published: (2022-11-01)

An overview of RNA splicing and functioning of splicing factors in land plant chloroplasts
by: Xuemei Wang, et al.
Published: (2022-12-01)

Splicing Outcomes of 5′ Splice Site GT>GC Variants That Generate Wild-Type Transcripts Differ Significantly Between Full-Length and Minigene Splicing Assays
by: Jin-Huan Lin, et al.
Published: (2021-08-01)

Tuning of NK-Specific HLA-C Expression by Alternative mRNA Splicing
by: Frederick J. Goodson-Gregg, et al.
Published: (2020-01-01)

Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes
by: Naoyuki Kataoka, et al.
Published: (2021-07-01)

Alternative Splicing and Isoforms: From Mechanisms to Diseases
by: Qi Liu, et al.
Published: (2022-02-01)